Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
Details
Publication Year 2025-11-13,Volume 16,Issue #1,Page 9822
Journal Title
Nature Communications
Publication Type
Nov 13
Abstract
Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis.
Publisher
Springer
Keywords
Animals; *Caspase 8/genetics/metabolism; *COVID-19/pathology/immunology/virology/genetics; Mice; *Inflammation/pathology/immunology/virology; *SARS-CoV-2/immunology; Mice, Knockout; Pyroptosis; CASP8 and FADD-Like Apoptosis Regulating Protein/metabolism/genetics; Humans; Disease Models, Animal; Interleukin-1beta/metabolism; Lung/pathology/virology/immunology; Apoptosis; Mice, Inbred C57BL; Signal Transduction; Viral Load; Necroptosis; Male; Female
Research Division(s)
Infection and Global Health; Blood Cells and Blood Cancer; Advanced Technology and Biology; Inflammation; Personalised Oncology
PubMed ID
41233351
Open Access at Publisher's Site
https://doi.org/10.1038/s41467-025-65098-z.
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-12-05 09:23:47
Last Modified: 2025-12-05 09:29:35
An error has occurred. This application may no longer respond until reloaded. Reload 🗙